Detalhe da pesquisa
1.
A randomized phase II trial evaluating safety and efficacy of an experimental chemotherapy regimen (irinotecan + oxaliplatin, IRINOX) and two standard arms (LV5 FU2 + irinotecan or LV5 FU2 + oxaliplatin) in first-line metastatic colorectal cancer: a study of the Digestive Group of the Fédération Nationale des Centres de Lutte Contre le Cancer.
Ann Oncol
; 18(12): 2000-5, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17785765
2.
Efficacy and safety of bevacizumab-based combination regimens in patients with previously untreated metastatic colorectal cancer: final results from a randomised phase II study of bevacizumab plus 5-fluorouracil, leucovorin plus irinotecan versus bevacizumab plus capecitabine plus irinotecan (FNCLCC ACCORD 13/0503 study).
Eur J Cancer
; 49(6): 1236-45, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23352604